Selective response to omalizumab in a patient with concomitant ncMCAS and POTS : what does it teach us about the underlying disease?Kačar, Mark (Avtor) Denman, S (Avtor) Savic, Sinisa (Avtor) mastocytosispostural orthostatic tachycardia syndromeomalizumabnonclonal mast cell activation syndromeESMON Publicidad20182021-04-08 14:56:14Neznano13875UDK: 616-097ISSN pri članku: 1698-0808DOI: 10.18176/jiaci.0251COBISS_ID: 58573827sl© 2018 Esmon Publicidad